mRNA Analytical Services
Curia utilizes leading technological methods for analyzing mRNA to meet needs from discovery to regulatory requirements.
- Curia offers comprehensive platforms for analyzing your products from early stage through drug substance and drug product release criteria.
- We provide both GMP and non-GMP testing proficiencies, specifically tailored for each phase of development.
- Our team prioritizes close collaboration and transparent communication, enabling you to stay informed and engaged. With on-site analytics, we deliver rapid turnaround times to keep your project moving efficiently.
- Our integrated approach covers all phases of drug development, including routine early-phase testing to customize manufacturing processes and clinical batch release.